Chronic treatment with antidepressant drugs reversibly alters NMDA mediated regulation of extracellular 5-HT in rat frontal cortex

Brain Research Bulletin

Volumn 70, Issue 1, 2006, Pages 62-67

  Owen, Jenny C E ^a   Whitton, Peter S ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

5 HT; Antidepressants; Cortex; Microdialysis; NMDA

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; N METHYL DEXTRO ASPARTIC ACID; PAROXETINE; REBOXETINE; SEROTONIN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; FRONTAL CORTEX; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; EXTRACELLULAR SPACE; FRONTAL LOBE; MALE; N-METHYLASPARTATE; RATS; RATS, WISTAR; SEROTONIN;

EID: 33646883912     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.03.020     Document Type: Article

References (26)

1. Adell A., and Artegas F. Differential effects of clomipramine on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. Naunyn-Schiedeberg's Arch. Pharmacol. 343 (1991) 237-244
2. Anath J. Treatment-resistant depression. Psychother. Psychosomatic 67 (1998) 61-70
3. Berman R.M., Cappiello A., Annand A., Oren D.A., Heninger G.R., Charney D.S., and Krystal J.H. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47 (2000) 351-354
4. Blier P., and De Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15 (1994) 230-236
5. Boyer P.A., Skolnick P., and Fossum L.H. Chronic administration of imipramine and citalopram alters the expression of NMDA subunit mRNA's in mouse brain. J. Mol. Neurosci. 10 (1998) 219-233
6. Bymaster F.P., Zhang W., Carter P.A., Shaw J., Chernet E., Phebus L., Wong D.T., and Perry K.W. Fluoxetine, but not other selective serotonin reuptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology 160 (2002) 353-361
7. 1A receptors. Br. J. Pharmacol. 142 (2004) 469-478
8. Layer R.T., Popik P., Olds T., and Skolnick P. Antidepressant-like action of the polyamine site antagonist, eliprodil (SL 82015). Pharmacol. Biochem. Behav. 52 (1995) 615-620
9. Lieberman J.A., Greenhouse J., Hamer R.M., Krishnan K.R., Nemeroff O., Sheenan D.V., Thase M.E., and Keller M.B. Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. Neuropsychopharmacology 30 (2005) 445-460
10. Maj J., and Rogoz Z. Synergistic effect of amantadine and imipramine in the forced swimming test. Pol. J. Pharmacol. 52 (2000) 111-114
11. Maj J., Rogoz Z., Skuza G., and Sowinska H. The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test. Pol. J. Pharmacol. 44 (1992) 337-346
12. Millan M.J., Lejeune F., and Gobert A. Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents. J. Psychopharmacol. 142 (2002) 114-138
13. Nakayama K. Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex. Naunyn Schmiedebergs Arch. Pharmacol. 365 (2002) 102-105
14. Owen J.C.E., and Whitton P.S. Effects of amatadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats. Br. J. Pharmacol. 145 (2005) 587-592
15. Pallotta M., Segieth J., and Whitton P.S. Chronic but not acute clomipramine alters the effect of NMDA receptor regulation of dopamine release in the rat frontal cortex. Neurosci. Lett. 262 (1999) 187-190
16. Pallotta M., Segieth J., and Whitton P.S. Chronic clomipramine administration reverses NMDA-evoked decreases in dopamine release in the raphe nuclei. Brain Res. 823 (1999) 217-220
17. Pallotta M., Segieth J., Sadideen F., and Whitton P.S. Repeated but not acute clomipramine decreases the effect of N-methyl-d-aspartate receptor activation on serotonergic transmission between the raphe nuclei and frontal cortex. Neuropharmacology 41 (2002) 294-300
18. Papp P., and Moryl E. Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur. J. Pharmacol. 263 (1994) 1-7
19. Paul I.A., Nowak G., Layer R.T., Popik P., and Skolnick P. Adaptation of the N-methyl-d-aspartate complex following chronic antidepressant treatments. J. Pharmacol. Exp. Ther. 269 (1994) 95-102
20. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Co-Ordinates (1982), Academic Press, New York
21. Rogoz Z., Skuza G., Maj J., and Danysz W. Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats. Neuropharmacology 42 (2002) 1024-1030
22. Rogoz Z., Skuza G., Kusmidern M., Woljicowski J., Kor M., and Danysz W. Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioural and pharmacokinetic studies. Pol. J. Pharmacol 56 (2004) 179-185
23. Skolnick P. Antidepressants for the new millennium. Eur. J. Pharmacol. 375 (1999) 31-40
24. Stryjer R., Strouss R.D., Shaked G., Bar F., Feldman B., Kotler M., Polak L., Rosenscwaig S., and Weizmann A. Amantadine as augmentation therapy in the management of treatment-resistant depression. Int. Clin. Psychopharmacol. 18 (2003) 93-96
25. Trullas R., and Skolnick P. Functional antagonists of the NMDA receptor complex exhibit antidepressant action. Eur. J. Pharmacol. 185 (1990) 1-10
26. Whitton P.S., Biggs C.S., Pearce B.R., and Fowler L.J. MK-801 increases extracellular 5-hydoxytryptamine in rat hippocampus and striatum in vivo. J. Neurochem. 58 (1992) 1573-1575